The Current Status for Metformin Use in Reproductive Medicine
Metformin has been used extensively in multiple reproductive settings to ameliorate hyperandrogenism and chronic anovulation, to treat infertility, to prevent miscarriage and to prevent later pregnancy complications as well. Metformin does result in modest improvements in the PCOS phenotype with reductions in circulating insulin and testosterone levels, weight loss, and improved menstrual/ovulatory frequency. It is relatively ineffective as a solo agent to treat infertility, and further has a relative anti-fecundity compared to clomiphene alone. Clomiphene remains the first choice for infertility therapy and the gold standard for women with PCOS. Metformin may be useful in preventing OHSS when used in conjunction with gonadotropins. The use of metformin to prevent pregnancy loss or to prevent pregnancy complications is still experimental and better trials are needed to guide therapy.
KeywordsMetformin PCOS Diabetes Ovulation induction Clomiphene citrate
- 1.Fujioka K, Brazg RL, Raz I et al (2005) Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies. Diabetes Obes Metab 7(1):28-39CrossRefPubMedGoogle Scholar
- 7.Moghetti P, Castello R, Negri C et al (2000) Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85(1):139-146CrossRefPubMedGoogle Scholar
- 10.Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F (2006) Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ 332(7556):1485CrossRefPubMedGoogle Scholar
- 11.Palomba S, Orio F Jr, Falbo A et al (2005) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90(7):4068-4074CrossRefPubMedGoogle Scholar
- 18.Palomba S, Orio F Jr, Nardo LG et al (2004) Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab 89(10):4801-4809CrossRefPubMedGoogle Scholar